G. Riegger

Fates of genetically engineered haematopoietic and mesenchymal stem cell grafts in normal and injured rat hearts

L. Kunz-Schughart, D. Griese, G. Riegger, 2008, Journal of tissue engineering and regenerative medicine.

Characteristics of multicellular spheroids formed by primary cultures of human thyroid tumor cells.

D. Grimm, J. Bauer, F. Hofstädter, 1997, Thyroid : official journal of the American Thyroid Association.

Wells’ syndrome associated with idiopathic hypereosinophilic syndrome

M. Landthaler, R. Schiffner, R. Büttner, 1997, The British journal of dermatology.

The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.

Janzen, A. M. Møller, D. Debanne, 1996, The Canadian journal of cardiology.

Do patients necessarily have to start with an angiotension converting enzyme inhibitor in the treatment of heart failure? Results of the CARMEN (Carvedilol ACE Inhibitor Remodeling Mild CHF Evaluation) study

S. Pocock, L. Rydén, M. Komajda, 2003 .

Replacement of angiotensin converting enzyme inhibition by carvedilol results in long-term reversed left ventricular remodeling in mild heart failure and is well tolerated: Results of the CARMEN (Carvedilol aceinhibitor remodeling in mild heart failure evaluation) study

L. Rydén, M. Komajda, W. Remme, 2003 .

Human follicular and papillary thyroid carcinoma cells interact differently with human venous endothelial cells.

D. Grimm, J. Bauer, F. Hofstädter, 1995, Thyroid : official journal of the American Thyroid Association.

Tumour necrosis factor‐α induced CD70 and interleukin‐7R mRNA expression in BEAS‐2B cells

M. Pfeifer, C. Schulz, K. Wolf, 2002, European Respiratory Journal.

Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women.

H. Schunkert, H. Hense, A. Danser, 1997, Circulation.